ARA open to working with pharmacy on biosimilars

The Australian Rheumatology Association says it is open to collaborating with pharmacy groups to get a biosimilar surveillance program up and running.

ARA President Dr Mona Marabani (pictured) says “it would make a lot of sense” to reach out to pharmacy groups about the proposal.

“We haven’t had any formal dialogue with the Pharmacy Guild or other pharmacy groups but I think this